Prognostic Implications of Plasma Volume Status Estimates in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT
- 4 February 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 21 (5) , 634-642
Abstract
Aims Plasma volume expansion is clinically and prognostically relevant in individuals with heart failure. Prior cohorts either excluded or had limited representation of patients with heart failure with preserved ejection fraction (HFpEF). We aimed to examine the relationship between calculated plasma volume status (PVS) and outcomes in HFpEF. Methods and results We included enrollees from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial (TOPCAT) with available haematocrit and weight data (n = 3414). Plasma volume was derived from the Hakim formula and compared to estimates of ideal plasma volume to generate a relative PVS. Multivariable Cox proportional hazards models tested the association of PVS with clinical outcomes. The median PVS was –11.9% (25th–75th percentile: –17.2% to –6.4%) and the majority (91.1%) had PVS consistent with relative volume contraction (PVS ≤ 0%) as opposed to volume expansion (8.9%, PVS > 0%). After multivariable adjustment, each 5% increment in PVS was associated with a ∼11%, 14%, and 12% higher risk for the primary composite endpoint, all‐cause death, and heart failure hospitalization, respectively (P < 0.002 for all), but not cardiovascular death (P = 0.051). After additional adjustment for natriuretic peptides, PVS only remained associated with heart failure hospitalization (HR 1.10, 95% confidence interval 1.001–1.21, P = 0.047). There were no significant interactions between spironolactone use and the PVS–risk relationship for any endpoint (P > 0.1 for all). Conclusion Higher calculated estimates of PVS were independently associated with a higher risk of long‐term clinical outcomes in HFpEF, and particularly, heart failure hospitalization.Keywords
Funding Information
- Texas Health Resources Clinical Scholarship
- Texas Health Resources Clinical Scholarship
This publication has 23 references indexed in Scilit:
- Calculated Estimates of Plasma Volume in Patients With Chronic Heart Failure—Comparison With Measured VolumesJournal of Cardiac Failure, 2018
- Plasma volume status predicts prognosis in patients with acute heart failure syndromesEuropean Heart Journal: Acute Cardiovascular Care, 2017
- Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort studyJournal of the Royal Society of Medicine, 2016
- Volume Overload Profiles in Patients With Preserved and Reduced Ejection Fraction Chronic Heart FailureJACC: Heart Failure, 2016
- Prognostic Value of Estimated Plasma Volume in Heart FailureJACC: Heart Failure, 2015
- Calculated Plasma Volume Status and Prognosis in Chronic Heart FailureEuropean Journal of Heart Failure, 2014
- Measurement of Blood Volume and Red Cell Mass: Re-examination of 51Cr and 125I MethodsBlood Cells, Molecules, and Diseases, 1996
- Adaptive changes in the periphery and their therapeutic consequencesThe American Journal of Cardiology, 1991
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990
- THE DISTRIBUTION OF RED CELLS AND PLASMA IN LARGE AND MINUTE VESSELS OF THE NORMAL DOG, DETERMINED BY RADIOACTIVE ISOTOPES OF IRON AND IODINE 1Journal of Clinical Investigation, 1946